|
|
| |
Program Director
|
 |
Alexandra S Wolff, PharmD, BCOP
Specialty: Adult Hematology, Oncology and Blood and Marrow Transplant
Pharmacy School: West Virginia University School of Pharmacy
PGY1 Residency: West Virginia University Medicine
PGY2 Residency in Hematology/Oncology: West Virginia University Cancer Institute and School of Pharmacy
About Dr. Wolff: Dr. Wolff joined LCI in February 2017 after 4 years with the WVU Cancer Institute as the outpatient BMT specialist and Director of Stem Cell Collections. Her professional interests include lymphoma and leukemia, cellular therapy, leadership and professional development, oncology pharmacy organization involvement, and resident development.
|
Preceptors
|
 |
Justin Arnall, PharmD, BCOP
Specialty: Classical Hematology and Hematologic Malignancies
Pharmacy School: UNC Eshelman School of Pharmacy
PGY1 Residency: Wake Forest Baptist Medical Center
PGY2 Residency in Hematology/Oncology: Wake Forest Baptist Medical Center
About Dr. Arnall: Dr. Arnall joined the CMC team in August 2016, and has worked as a clinical specialist with the Levine Cancer Institute as well as (currently) the Specialty Pharmacy Service. His professional interests include bleeding disorders, myeloproliferative neoplasms, and thrombotic microangiopathies, as well as innovations in pharmacy practice and hematology pharmacy education. He is an active member in HOPA, ACCP, ASTCT, and NCOP. His primary practice sites include the CMC inpatient hematology consult service and specialty pharmacy service bleeding disorders and hematology service lines.
|
 |
Ryan Bender, PharmD
Specialty: Investigational Drug Services
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Duquesne University – Mylan School of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
About Dr. Bender: Dr. Bender joined Atrium Health in 2007 as a pharmacist resident. He then transferred to working primarily within the surgical trauma ICU and medical ICU while also serving as a medication safety pharmacist for the inpatient pharmacy. He transferred to IDS in 2009 and currently serves as the supervisor for IDS to coordinate clinical drug studies for a variety of disease states across Atrium Health.
|
 |
Miranda Benfield, PharmD, BCOP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School:Wingate University School of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency: Carolinas Medical Center
About Dr. Benfield: Dr. Benfield joined Levine Cancer Institute in July 2021 after completing her residency. Her interests include solid tumor oncology such as gynecology oncology where she focuses in her primary outpatient clinic practice site.
|
 |
Jessica Michaud Davis, PharmD, BCOP, CPP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Medical University of South Carolina
PGY1 Pharmacy Residency: Boston Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: University of North Carolina Hospitals and Clinics
About Dr. Davis: Dr. Davis joined the Department of Pharmacy at CMC in August 2016. Her primary interests include solid tumors, such as melanoma and renal cell carcinoma, and immunotherapy.
|
 |
Peter DeLaney, PharmD, MBA
Specialty: Administration/Oncology
Pharmacy School: Purdue University
PGY1 Pharmacy Residency: Carolinas Medical CenterAbout Dr. DeLaney: Dr. DeLaney began his career at Atrium Health in July of 2010 as a PGY1 resident at Atrium Health Carolinas Medical Center. He transitioned in 2012 to Atrium Health Cabarrus where he specialized in Emergency Medicine. In 2018, he became the Pharmacy Operations Manager for Atrium Health Cabarrus where he worked on market, regional, and enterprise-wide initiatives while obtaining his MBA. Dr. DeLaney now serves as the Director of Pharmacy where he focuses on process improvement and patient equity.
|
 |
Grace Elsey, PharmD, BCOP
Specialty: Hematology/Transplant and Cellular Therapy
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Medical University of South Carolina
PGY1 Pharmacy Residency: Wake Forest Baptist Health
PGY2 Pharmacy Residency in Hematology/Oncology: Wake Forest Baptist Health
About Dr. Elsey: Dr. Elsey joined Levin Cancer Institute in July 2021 after completing her residency training. Her interests include hematologic malignancies, anticoagulation, infectious diseases in immunocompromised patients, and the adolescent and young adult population.
|
 |
Amy Ellenburg, PharmD, BCOP
Specialty: Pediatric Hematology and Oncology
Site: Levine Children’s Hospital
Pharmacy School: University of North Carolina at Chapel Hill
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: (pediatric-focused): Memorial Sloan Kettering Cancer Center
About Dr. Ellenburg: Dr. Ellenburg joined the pharmacy department in January 2021 after spending almost three years practicing in pediatric hematology and oncology at Geisinger Medical Center. Her professional interests include benign and malignant hematologic disorders, bone marrow transplant, and supportive care in pediatric oncology patients.
|
 |
Mei Ka Fong, PharmD, BCOP, CPP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center
Pharmacy School: University of Rhode Island
PGY1 Pharmacy Residency: Veterans Affairs Medical Center of Northport
PGY2 Pharmacy Residency in Hematology/Oncology: Roswell Park Cancer Institute
About Dr. Fong: Dr. Fong joined the department of pharmacy at CMC in 2015 after four years as a clinical pharmacy specialist in medical oncology and two years as the PGY2 oncology residency program director at Roswell Park Cancer Institute in Buffalo, NY. She has a particular interest in gastrointestinal, neuroendocrine cancers, and health literacy.
|
 |
Sarah Hanson, PharmD, BCOP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: UNC Eshleman School of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: Carolinas Medical Center/Levine Cancer Institute
About Dr. Hanson: Dr. Hanson joined Levine Cancer Institute in July 2021 after completing her residency training. Her interests include solid tumors such as gastrointestinal malignancies, pharmacogenomics, supportive care, and pharmacy practice advancement. Her primary outpatient oncology clinic practice site is the GI Clinic.
|
 |
Hailey Hill, PharmD, BCOP
Specialty: Hematology/Transplant and Cellular Therapy
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: UNC Eshleman School of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: Carolinas Medical Center/Levine Cancer Institute
About Dr. Hill: Dr. Hill joined Levine Cancer Institute in August 2020 after completing her residency training. Her interests include hematology malignancies, stem cell transplant, and anticoagulation in the cancer population.
|
 |
Rupal Jaffa, PharmD, MBA, BCPS, BCIDP
Specialty: Infectious Diseases
Site: Carolinas Medical Center
Pharmacy School: UNC Eshleman School of Pharmacy
PGY1 Pharmacy Residency: University of Wisconsin Hospital and Clinics
PGY2 Pharmacy Residency in Hematology/Oncology: Carolinas Medical Center
About Dr. Jaffa: Dr. Jaffa joined the pharmacy department at CMC in 2018 after completing her PGY2 Infectious Diseases residency at CMC. She currently serves as the Clinical Team Leader for the Central Division of ASN. Her professional interests include medical and pharmacy experiential education, the treatment of multidrug resistant organisms, the management of infections in immunocompromised populations, and the optimization of antimicrobials in patients with antibiotic allergies.
|
 |
Allison Karabinos, PharmD, BCOP
Specialty: Adult Hematology, Oncology and Blood & Marrow Transplantation
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: The University of North Carolina Eshelman School of Pharmacy
PGY1 Residency: Methodist University Hospital
PGY2 Residency in Hematology/Oncology: Levine Cancer Institute
About Dr. Karabinos: Dr. Karabinos joined the LCI team in August 2019. Her professional interests include hematologic malignancies, hematopoietic stem cell transplantation, infectious diseases in the immunocompromised patient population, and pharmacogenomics.
|
 |
Cindy Klotz, PharmD, MS, CPP, DPLA
Specialty: Pediatric Stem Cell Transplant and Cellular Therapies
Site: Levine Children’s Hospital
Pharmacy School: University of Cincinnati
About Dr. Klotz: Dr. Klotz joined the LCH team in October of 2018. She started her career at Cincinnati Children’s Hospital Medical Center as an intern and then moving into the Hematology/Oncology world. She quickly cross- covered the BMT patients. She enjoys precepting all students and has been the intern manager in the past. Her current interested are viral specific t cells and gene therapy.
|
 |
Jessica McElwee, PharmD, BCOP
Specialty: Adult Hematology, Oncology and Blood & Marrow Transplantation
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Wingate University School of Pharmacy
PGY1 Residency: Medical University of South Carolina
PGY2 Residency in Hematology/Oncology: Medical University of South Carolina
About Dr. McElwee: Dr. McElwee joined the LCI team in September 2020. Her professional interests include hematologic malignancies, hematopoietic stem cell transplantation, and infectious diseases in the immunocompromised patient population.
|
 |
Shelby Merchant, PharmD, BCOP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: University of South Carolina College of Pharmacy
PGY1 Residency: Carolinas Medical Center
PGY2 Residency in Hematology/Oncology: Vanderbilt University Medical Center
About Dr. Merchant: Dr. Merchant joined the oncology pharmacy team at LCI in July 2021 after spending two years as a thoracic oncology pharmacy specialist at Memorial Sloan Kettering Cancer Center in New York City. Dr. Merchant works primarily in the thoracic and head/neck outpatient oncology clinics. Her professional interests include precision medicine, palliative care, and immuno-oncology.
|
 |
Meghan D. Michael, PharmD, BCOP
Specialty: Pediatric Hematology and Oncology
Site: Levine Children's Hospital
Pharmacy School: University of Georgia College of Pharmacy
PGY1 Pharmacy Residency: Medical College of Georgia/University of Georgia College of Pharmacy
PGY2 Pharmacy Residency in Hematology/Oncology: Wake Forest Baptist Medical Center
About Dr. Devine: Dr. Devine joined the pharmacy department at CMC in July 2013. Her interests include acute leukemias, osteosarcoma, oncologic emergencies, and lymphoma.
|
 |
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP
Specialty: Hematology/Oncology, Administration/Oncology
Site: Levine Cancer
Pharmacy School: Massachusetts College of Pharmacy and Health Sciences
PGY1 Residency: Steward St. Elizabeth’s Medical Center
About Dr. Moore: Dr. Moore joined Atrium Health and Levine Cancer Institute in 2016. His clinical interests include lymphoma, multiple myeloma, chronic leukemias, ITP, and thrombotic microangiopathies as well as pharmacovigilance, professional writing, and research. He is an active member of ACCP, ASHP, HOPA, and APSHO. He is also a graduate of the ASHP Foundation Pharmacy Leadership Academy and a Fellow of ACCP.
|
 |
Sarah Morris, PharmD
Specialty: Pharmacogenomics
Pharmacy School: University of California San Diego
PGY1 Residency: Stanford Health Care
PGY2 Residency in Clinical Pharmacogenomics: St. Jude Children's Research Hospital
About Dr. Morris: Dr. Morris joined Atrium Health in 2021 as a Clinical Pharmacogenomics Specialist in the Division of Cancer Pharmacology & Pharmacogenomics. Her professional interests include translational and clinical pharmacogenomics research and integrating pharmacogenomic results and clinical decision support in the electronic medical record.
|
 |
Allison Morse, PharmD, BCOP
Specialty: Adult Hematology, Oncology and Blood & Marrow Transplant
Pharmacy School: University of Iowa College of Pharmacy
PGY1 Residency: Froedtert & the Medical College of Wisconsin
PGY2 Residency in Hematology/Oncology: Froedtert & the Medical College of Wisconsin
About Dr. Martin: Dr. Morse joined the CMC team in September 2017. Her professional interests include hematologic malignancies, bone marrow transplantation, pharmacogenomics in oncology practice, and pharmacy practice advancement.
|
 |
Grace Nguyen, PharmD, BCPS
Specialty: Cancer/Pharmacogenomics Research
Site: Levine Cancer
Pharmacy School: St Louis College of Pharmacy
PGY1 Pharmacy Residency: Ascension SE Wisconsin Hospital - St. Joseph
PGY2 Pharmacy Residency in Clinical Pharmacogenomics: University of Chicago Medicine
About Dr. Nguyen: Dr. Nguyen joined Levine Cancer Institute in 2022 after completing her residency training. Her interests include implementation and clinical research of pharmacogenomics in oncology, psychiatry and cardiology.
|
 |
Meagan Griffin Reinfried, PharmD, BCOP
Specialty: Adult Hematology, Oncology and Blood and Marrow Transplantation
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: The University of North Carolina Eshelman School of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: Memorial Sloan Kettering Cancer Center
About Dr. Reinfried: Dr. Reinfried joined Levine Cancer Institute in 2020 after four years as a bone marrow transplant clinical specialist at Memorial Sloan Kettering Cancer Center. Her professional interests include acute leukemias, bone marrow transplantation and cellular therapies, and management of post-transplant complications.
|
|
Cindy Riddagh, BS, PharmD
Specialty: Administration/Oncology
Site: Levine Cancer
Pharmacy School: St. John’s University School of Pharmacy (BS); University of Florida (PharmD)
About Dr. Riddagh: Dr. Riddagh joined Atrium Health in April 2010 as the supervisor of the sterile compounding area at Carolinas Medical Center. Her current role is oncology pharmacy manager for the 16 Levine Cancer regional sites. In 2016, Dr. Riddagh completed the ASHP Pharmacy Leadership Academy. Her interests include process improvement and leadership development.
|
| |
Katherine Taylor, PharmD, MBA, BCOP
Specialty: Adult Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Medical University of South Carolina
PGY1 Pharmacy Residency: Wake Forest Baptist Health
PGY2 Pharmacy Residency in Hematology/Oncology: Wake Forest Baptist Health
About Dr. Taylor:Dr. Taylor joined Levine Cancer in December 2022 after completing her residency training. Her interests include solid tumor oncology, specifically sarcomas, supportive care, and the adolescent and young adult population.
|
 |
Thuy Tran, PharmD, BCOP, CSP
Site: Atrium Health Specialty Pharmacy Services
Pharmacy School: University of South Carolina College of Pharmacy
About Dr. Tran: Dr. Tran is the lead pharmacist for the adult oncology service line at Atrium Health Specialty Pharmacy Service (AH SPS) and has been with the system for over 7 years. She was a recipient of the 40-Under-40 in Cancer in 2021 for jer effort in the initiation of the AH SPS pediatric oncology/hematology service line, the optimization of the AH SPS hematology service line, and the COVID community outreach.
|
 |
Megan Wayman, PharmD, BCOP
Specialty: Adult Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: University of South Carolina College of Pharmacy
PGY1 Pharmacy Residency: Carolinas Medical Center
PGY2 Pharmacy Residency in Hematology/Oncology: Carolinas Medical Center/Levine Cancer
About Dr. Wayman: Dr. Wayman joined Levine Cancer in July 2022 after completing her residency training. Her interests include solid tumors, primarily CNS tumors, and pharmacy practice advancement. Her outpatient oncology clinic practice site is in the neuro-oncology and genitourinary oncology clinics.
|
 |
Julie Ziegengeist, PharmD, BCOP
Specialty: Hematology/Oncology
Site: Carolinas Medical Center and Levine Cancer
Pharmacy School: Virginia Commonwealth University School of Pharmacy
PGY1 Residency: Virginia Commonwealth University Health System
PGY2 Residency in Hematology/Oncology: Virginia Commonwealth University Health System
About Dr. Ziegengeist: Dr. Ziegengeist joined Levine Cancer Institute in July 2019 after completing her residency training. Her interests include solid tumors such as breast cancer, which is her primary outpatient oncology clinic practice site.
|
